BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 18510894)

  • 1. Management of hepatitis B virus co-infection on and off antiretroviral therapy.
    Soriano V; Vispo E; Bottecchia M; Sheldon J; Tuma P; Garcia-Samaniego J; Barreiro P
    Curr HIV/AIDS Rep; 2008 May; 5(2):86-93. PubMed ID: 18510894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The implications of antiviral drugs with activity against hepatitis B virus and HIV.
    Bottecchia M; Garcia-Samaniego J; Soriano V
    Curr Opin Infect Dis; 2007 Dec; 20(6):621-8. PubMed ID: 17975413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral hepatitis and HIV co-infection.
    Soriano V; Vispo E; Labarga P; Medrano J; Barreiro P
    Antiviral Res; 2010 Jan; 85(1):303-15. PubMed ID: 19887087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients.
    Selabe SG; Lukhwareni A; Song E; Leeuw YG; Burnett RJ; Mphahlele MJ
    J Med Virol; 2007 Nov; 79(11):1650-4. PubMed ID: 17854040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of chronic hepatitis B in HIV co-infected patients].
    Massard J; Benhamou Y
    Gastroenterol Clin Biol; 2008 Jan; 32(1 Pt 2):S20-4. PubMed ID: 18662606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management and treatment of chronic hepatitis B in HIV-positive patients.
    Soriano V; de Mendoza C; Fernández-Montero JV; Labarga P; Barreiro P
    Ann Med; 2014 Aug; 46(5):290-6. PubMed ID: 24716736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus and HIV infection.
    Martín-Carbonero L; Poveda E
    Semin Liver Dis; 2012 May; 32(2):114-9. PubMed ID: 22760650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open-label study of tenofovir in HIV-1 and Hepatitis B virus co-infected individuals.
    Nelson M; Portsmouth S; Stebbing J; Atkins M; Barr A; Matthews G; Pillay D; Fisher M; Bower M; Gazzard B
    AIDS; 2003 Jan; 17(1):F7-10. PubMed ID: 12478090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Special considerations and treatment of patients with HBV-HIV coinfection.
    Dieterich DT
    Antivir Ther; 2007; 12 Suppl 3():H43-51. PubMed ID: 18284182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of tenofovir-containing antiretroviral therapy on chronic hepatitis B in a cohort co-infected with human immunodeficiency virus.
    Stephan C; Berger A; Carlebach A; Lutz T; Bickel M; Klauke S; Staszewski S; Stuermer M
    J Antimicrob Chemother; 2005 Dec; 56(6):1087-93. PubMed ID: 16269552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B in HIV-infected patients.
    Soriano V; Poveda E; Vispo E; Barreiro P
    Clin Liver Dis; 2013 Aug; 17(3):489-501. PubMed ID: 23905818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus variants in an HIV-HBV co-infected patient at different periods of antiretroviral treatment with and without lamivudine.
    Santos EA; Sucupira MV; Arabe J; Gomes SA
    BMC Infect Dis; 2004 Aug; 4():29. PubMed ID: 15339340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B and human immunodeficiency virus co-infection.
    Phung BC; Sogni P; Launay O
    World J Gastroenterol; 2014 Dec; 20(46):17360-7. PubMed ID: 25516647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatitis B in patients with HIV infection].
    Barreiro P; Martín-Carbonero L; García-Samaniego J
    Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 7():71-9. PubMed ID: 19100234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B in HIV patients: what is the current treatment and what are the challenges?
    Soriano V; Tuma P; Vispo E; Labarga P; Fernández JV; Medrano J; Barreiro P
    J HIV Ther; 2009 Mar; 14(1):13-8. PubMed ID: 19731560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The course and treatment of chronic hepatitis B in HIV-infected patients].
    Maksimov SL; Tsarenko SP; Kravchenko AV; Iushchuk ND
    Ter Arkh; 2010; 82(11):32-7. PubMed ID: 21381346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virology and clinical sequelae of long-term antiviral therapy in a North American cohort of hepatitis B virus (HBV)/human immunodeficiency virus type 1 (HIV-1) co-infected patients.
    Coffin CS; Osiowy C; Myers RP; Gill MJ
    J Clin Virol; 2013 Jun; 57(2):103-8. PubMed ID: 23465393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of patients co-infected with hepatitis B virus and HIV.
    Núñez M; Soriano V
    Lancet Infect Dis; 2005 Jun; 5(6):374-82. PubMed ID: 15919623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of hepatitis B virus resistance for lamivudine in chronic hepatitis B patients co-infected with the human immunodeficiency virus in a Dutch cohort.
    Wolters LM; Niesters HG; Hansen BE; van der Ende ME; Kroon FP; Richter C; Brinkman K; Meenhorst PL; de Man RA
    J Clin Virol; 2002 Apr; 24(3):173-81. PubMed ID: 11856618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-HIV activity of entecavir: a multicentre evaluation of lamivudine-experienced and lamivudine-naive patients.
    Sasadeusz J; Audsley J; Mijch A; Baden R; Caro J; Hunter H; Matthews G; McMahon MA; Olender SA; Siliciano RF; Lewin SR; Thio CL
    AIDS; 2008 May; 22(8):947-55. PubMed ID: 18453854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.